XBiotech (XBIT) stock price, revenue, and financials

XBiotech market cap is $510.9 m, and annual revenue was $44 m in FY 2020

$510.9 M

XBIT Mkt cap, 07-May-2021

$44 M

XBiotech Revenue FY, 2020
XBiotech Gross profit (FY, 2020)9.4 M
XBiotech Gross profit margin (FY, 2020), %21.5%
XBiotech Net income (FY, 2020)-11.2 M
XBiotech EBIT (FY, 2020)-18.3 M
XBiotech Cash, 31-Dec-2020237.4 M

XBiotech Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

44.0m

Cost of goods sold

34.5m

Gross profit

9.4m

Gross profit Margin, %

21%

R&D expense

26.4m15.7m24.1m9.5m

General and administrative expense

7.6m5.3m7.1m18.2m

Operating expense total

34.1m21.0m31.2m27.7m

EBIT

(34.1m)(21.0m)(31.2m)(18.3m)

EBIT margin, %

(42%)

Interest income

354.0k400.0k564.0k

Investment income

2.5m

Pre tax profit

718.5m(12.8m)

Income tax expense

49.8m(1.6m)

Net Income

(33.1m)(21.1m)668.6m(11.2m)

EPS

(0.9)(0.6)17.2

Quarterly

USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

12.7m15.5m10.5m

Cost of goods sold

9.7m13.2m9.4m

Gross profit

3.0m2.3m1.1m

Gross profit Margin, %

24%15%11%

R&D expense

3.0m3.9m3.9m4.5m4.7m4.5m1.2m2.6m2.3m

General and administrative expense

1.2m1.7m1.2m1.3m1.3m1.6m4.0m6.2m3.4m

Operating expense total

4.2m5.6m5.1m5.8m6.0m6.1m5.2m8.8m5.8m

EBIT

(4.1m)(5.6m)(5.1m)(5.8m)(6.0m)(6.1m)(2.2m)(6.5m)(4.7m)

EBIT margin, %

(17%)(42%)(44%)

Interest income

64.0k107.0k100.0k78.0k51.0k250.0k1.9m306.0k124.0k

Pre tax profit

(366.0k)(7.2m)(3.2m)

Income tax expense

(352.0k)(332.0k)(668.0k)

Net Income

(4.1m)(5.9m)(5.1m)(5.9m)(5.9m)(6.1m)(14.0k)(6.8m)(2.5m)

EPS

(0.1)(0.2)(0.1)(0.2)(0.2)(0.1)(0.2)(0.1)

XBiotech Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(33.1m)(21.1m)668.6m(11.2m)

Depreciation and Amortization

1.5m2.4m2.4m2.2m

Accounts Receivable

(4.1m)

Accounts Payable

(2.7m)(78.0k)496.0k(334.0k)

Cash From Operating Activities

(33.6m)(16.5m)(18.3m)(65.1m)

Purchases of PP&E

(1.4m)(122.0k)(204.0k)(3.7m)

Cash From Investing Activities

(1.4m)(122.0k)674.8m(3.7m)

Cash From Financing Activities

33.3m201.0k42.1m(409.7m)

Net Change in Cash

(2.6m)(15.9m)698.8m(477.2m)

Income Taxes Paid

54.1m

XBiotech Ratios

USDFY, 2017

Financial Leverage

1 x

XBiotech Employee Rating

2.835 votes
Culture & Values
2.9
Work/Life Balance
3.3
Senior Management
2.6
Salary & Benefits
2.6
Career Opportunities
2.7
Source